Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label…

Overview of attention for article published in Trials, December 2019

Altmetric Badge

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 2,417 followers.

RT @filimasini: Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition ... http…

01 Nov 2021

Reply Repost Favourite

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition ... https://t.co/9T6SSO91YF

01 Nov 2021

Reply Repost Favourite

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition ... https://t.co/9T6SSO91YF

28 Aug 2021

Reply Repost Favourite

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN) https://t.co/9

19 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.